VEGFR-2-IN-31
VEGFR-2-IN-31 (compound 3i) is a potent VEGFR-2 inhibitor (IC50=8.93 nM), and an anti-prostate cancer agent. VEGFR-2-IN-31 arrests cell cycle at the S-phase and induces apoptosis.
Product Specifications
UNSPSC
12352005
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vegfr-2-in-31.html
Solubility
10 mM in DMSO
Smiles
O=C1NN=C(C2=CC=CC=C2)/C1=N/NC3=CC=C(C=C3F)F
Molecular Formula
C15H10F2N4O
Molecular Weight
300.26
References & Citations
[1]Soliman DH, et al. Design, synthesis, and docking studies of novel pyrazole-based scaffolds and their evaluation as VEGFR2 inhibitors in the treatment of prostate cancer. RSC Adv. 2023 Jul 10;13 (30) :20443-20456.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Yyj4414-50gEcoli 50 µg (E. coli)
Recombinant Mycobacterium Marinum MMAR_0356 Protein (aa 1-310)
Sign In for Pricing
View Details 